Sun Pharma Advanced Research Company has allotted 84,26,966 equity shares of Re 1 each on conversion of equivalent number of convertible warrants.
Post the above allotment, the paid up capital of the Company has increased from Rs. 26,34,52,000 (26,34,52,000 equity shares of face value of Re. 1/- each fully paid up) to Rs. 27,18,78,966/- (27,18,78,966 equity shares of face value of Re. 1/- each fully paid up).
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
